Expression of hepatitis C virus core protein associated with malignant lymphoma in transgenic mice

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 26, Issue 2, 2003, Pages 115-124

  Ishikawa, Takayuki ^a   Shibuya, Kazumoto ^a   Yasui, Kotaro ^b   Mitamura, Keiji ^c   Ueda, Susumu ^a  

^a NIPPON INSTITUTE FOR BIOLOGICAL SCIENCE   (Japan)

^b Tokyo Metropolitan Cancer Detection Center   (Japan)

^c SHOWA UNIVERSITY   (Japan)

Author keywords

B cell non Hodgkin's lymphoma; Core protein; Hepatitis C virus; Hepatocellular adenoma; Malignant lymphoma; Transgenic mouse

Indexed keywords

CORE PROTEIN; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; B CELL LYMPHOMA; CARCINOGENESIS; CELL TYPE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; DISEASE MODEL; HEPATITIS C; HEPATITIS C VIRUS; LIVER ADENOMA; LIVER CELL CARCINOMA; LYMPHADENOPATHY; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MOUSE; NONHODGKIN LYMPHOMA; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TRANSGENIC MOUSE;

HEPATITIS C VIRUS; MUS MUSCULUS;

EID: 0037367036     PISSN: 01479571     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0147-9571(02)00038-3     Document Type: Article

References (28)

1. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244: 359-62.
2. Chien DY, Choo QL, Ralston R, Spaete R, Tong M, Houghton M, Kuo G. Persistence of HCV despite antibodies to both putative envelope glycoproteins. Lancet 1993;342:933.
3. Bruix J, Barrera JM, Calvet X, Ercilla G, Costa J, Sanchez-tapias JM, Ventura M, Vall M, Bruguera M, Bru C, Castillo R, Rodes J. Prevalence of antibodies to hepatitis C virus in spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989;ii:1004-6.
4. Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe Y, Koi S, Onji M, Ohta Y. Hepatitis C virus infection is associated with development of hepatocellular carcinoma. Proc Natl Acad Sci USA 1990;87:6547-9.
5. Casato M, Taliani G, Pucillo LP, Goffredo F, Lagana B, Bonomo L. Cryoglobulinemia and hepatitis C virus. Lancet 1991;337:1047-8.
6. Cacoub P, Fabiani FL, Musset L, Perrin M, Frangeul L, Leger JM, Huraux J-M, Piette J-C, Godeau P. Mixed cryoglobulinemia and hepatitis C virus. Am J Med 1994;96:124-32.
7. Zignego AL, Ferri C, Giannini C, Civita LL, Gareccia G, Longombardo G, Bellesi G, Caracciolo F, Thiers V, Gentilini P. Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role. Arch Virol 1997;142: 545-55.
8. Silvestri F, Barillari G, Fanin R, Pipan C, Falasca E, Salmaso F, Zaja F, Infanti L, Patriarca F, Botta GA, Baccarani M. Hepatitis C virus infection among cryoglobulinemic and non-cryoglobulinemic B-cell non-Hodgkin's lymphomas. Haematologica 1997;82:314-7.
9. Yasui K, Wakita T, Tsukiyama-Kohara K, Funahashi S, Ichikawa M, Kajita T, Moradpour D, Wands JR, Kohar M. The native form and maturation process of hepatitis C virus core protein. J Virol 1998;72:6048-55.
10. Chiba J, Ohba H, Matsuura Y, Watanabe Y, Katayama S, Kikuchi S, Saito I, Miyamura T. Serodiagnosis of hepatitis C virus (HCV) infection with an HCV core protein molecularly expressed by a recombinant baculovirus. Proc Natl Acad Sci USA 1991;88:4641-5.
11. Marusawa H, Hijikata M, Chiba T, Shimotohno K. Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-κ B activation. J Virol 1990;73: 4713-20.
12. Ray RB, Lagging LM, Meyer K, Steele R, Ray R. Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein. Virus Res 1995;37:209-20.
13. Ray RB, Steele R, Meyer K, Ray R. Transcriptional repression of p53 promoter by hepatitis C virus core protein. J Biol Chem 1997;272:10983-6.
14. Ray RB, Lagging LM, Meyer K, Ray R. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J Virol 1996;10:4438: 4443.
15. Tsuchihara K, Hijikata M, Fukuda K, Kuroki T, Yamamoto N, Shimotohno K. Hepatitis C virus core protein regulates cell growth and signal transduction pathway transmitting growth stimuli. Virology 1999;258:100-7.
16. Zhu N, Khoshnan A, Schneider R, Matsumoto M, Dennert G, Ware C, Lai MMC. Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol 1998;72:3691-7.
17. Zhao X, Araki K, Miyazaki J, Yamamura K. Developmental and liver-specific expression directed by the serum amyloid P component promoter in transgenic mice. J Biol Chem 1992; 111:736-8.
18. Hogan B, Costantini F, Lacy E. Manipulating the mouse embryo: a laboratory manual. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press; 1989.
19. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakawa Y, Mayumi M. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992;73:673-9.
20. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning, a laboratory manual, 2nd ed. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press; 1989.
21. Kawasaki ES. Detection of gene expression. In: Herry AE, editor. PCR technology. New York: Stockton Press; 1989. p. 89-97.
22. Frith CH, Ward JM, Frederickson T, Harleman JH. In: Mohr U, editor. Pathobiology of the aging mouse. Washington, DC: ILSI Press; 1996. p. 219-35.
23. Koike K, Moriya K, Ishibashi K, Matsuura Y, Suzuki T, Saito I, Iino S, Kurokawa K, Miyamura T. Expression of hepatitis C virus envelope proteins in transgenic mice. J Gen Virol 1995;76:3031-8.
24. Pasquinelli C, Shoenberger JM, Chung J, Chang K-M, Guidotti LG, Selby M, Berger K, Lesniewski R, Houghton M, Chisari FV. Hepatitis C virus core and E2 protein expression in transgenic mice. Hepatology 1997;25:719-27.
25. Kawamura T, Furusaka A, Koziel MJ, Chung RT, Wang TC, Schmidt EV, Liang TJ. Transgenic expression of hepatitis C virus structural proteins in the mouse. Hepatology 1997; 25:1014-21.
26. Moriya K, Hajime F, Shintani Y, Yotsuyanagi H, Tsutsumi T, Ishibashi K, Matsuura Y, Kimura S, Miyamura T, Koike K. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 1998;4:1065-7.
27. De Vita S, Sansonno D, Dolcetti R, Ferraccioli G, Carbone A, Cornacchiulo V, Santini G, Crovatto M, Gloghini A, Dammacco F, Boiocchi M. Hepatitis C virus within a malignant lymphoma lesion in the course of Type II mixed cryoglobulinemia. Blood 1995;86:1887-92.
28. Sansonno D, De Vita S, Cornacchiulo V, Carbone A, Boiocchi M, Dammacco F. Detection and distribution of hepatitis C virus-related proteins in lymph nods of patients with type II mixed cryoglobulinemia and neoplastic or non-neoplastic lymphoproliferation. Blood 1996;88: 4638-45.